Identifying and definitional attributes | |
Metadata item type: | Data Element |
---|---|
Short name: | Hypertension - treatment |
METEOR identifier: | 302442 |
Registration status: | Health!, Standard 21/09/2005 |
Definition: | Whether a person is currently being treated for hypertension (high blood pressure) using antihypertensive medication, as represented by a code. |
Data Element Concept: | Person—hypertension treatment with antihypertensive medication indicator |
Value Domain: | Yes/no/not stated/inadequately described code N |
Collection and usage attributes | |
Guide for use: | CODE 9 Not stated/inadequately described This code is not for use in primary data collections. |
---|
Data element attributes | |
Collection and usage attributes | |
Guide for use: | CODE 1 Yes Record if a person is currently being treated for hypertension using antihypertensive medication. CODE 2 No Record if a person is not currently being treated for hypertension using antihypertensive medication. |
---|---|
Collection methods: | Ask the individual if he/she is currently treated with anti-hypertensive medications. Alternatively obtain the relevant information from appropriate documentation. |
Source and reference attributes | |
Submitting organisation: | National diabetes data working group |
Origin: | National Diabetes Outcomes Quality Review Initiative (NDOQRIN) data dictionary. |
Reference documents: | Pahor M, Psaty BM, Furberg CD. Treatment of hypertensive patients with diabetes. Lancet 1998; 351:689-90. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group [erratum appears in Br Med J 1999; 318:29]. Br Med J 1998; 317:703-13. Grossman E, Messerli FH, Goldbourt U, Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996; 276:1886-92. Hypertension in diabetes [Australian Prescriber Feb 2002]. American Journal of Preventive Medicine 2002;21. |
Relational attributes | |
Related metadata references: | Supersedes Person—hypertension treatment status (antihypertensive medication), code N Health!, Superseded 21/09/2005 |
Implementation in Data Set Specifications: | Acute coronary syndrome (clinical) DSS Health!, Superseded 01/09/2012 Acute coronary syndrome (clinical) DSS Health!, Superseded 02/05/2013 Acute coronary syndrome (clinical) NBPDS 2013- Health!, Standard 02/05/2013 Implementation start date: 01/07/2013 Diabetes (clinical) NBPDS Health!, Standard 21/09/2005 DSS specific information: Hypertension is probably the most important public health problem in developed countries. It is common, asymptomatic, readily detectable, usually easily treatable, and often leads to lethal complications if left untreated. Elevated blood pressure (Hypertension) is a recognised risk for microvascular and macro vascular complications of diabetes (coronary, cerebral and peripheral). Hypertension is elevated arterial blood pressure above the normal range (130 to 139/85 to 89 mm Hg) and values above these are defined as hypertension. Lower levels of target blood pressure should be aimed for in specific groups, e.g. in diabetics aim for blood pressure less than 135/80 mm Hg. Many diabetics fail to control high blood pressure. Among all the diabetics with high blood pressure, 29% were unaware that they had high blood pressure and only slightly more than half were receiving hypertensive medications as treatment. Antihypertensives - Australian Medicines Handbook: February, 2001. Tight blood control in diabetes usually requires combination therapy as stated by (Australian Diabetes society) Therapeutic Guidelines Limited (05.04.2002). People taking antihypertensives are also encouraged to make healthy lifestyle changes, such as quit smoking, lose weight and have regular physical activity. Systematic reviews of studies that have reported outcomes in patients with diabetes and hypertension indicate that combination therapy is frequently required and may be more beneficial than monotherapy. In the past multi-drug therapy to control hypertension has not been advocated much, but according to the special report published in the American Journal of Kidney Diseases, if ACE inhibitor therapy alone doesn't achieve good blood pressure control, multi-drug therapy should be implemented. (Heart Center Online) |